Data sources:
Data collection started on 10 February 2020 and finished on 14 August 2020. We have chosen random patients from ENT rhinology and immunology clinics. During Pre-COVID phase of this survey, patients who came to attend clinic were verbally asked if they are using steroid nose spray and if they want to be a part of the survey. If the answer to both the questions was “yes” then the survey responses were recorded from those patients. Similarly, during COVID-19 outbreak, patients booked into the clinic who were using steroid nose spray were contacted by phone and if they agreed to be a part of this survey then their responses were recorded.
Study size : Data was collected from 100 patients.